Circulatory Support Devices Market By Product (Total Artificial Heart, Ventricular Assist Device, Extracorporeal Membrane Oxygenation), By Usage Area (Hospitals, Ambulatory Centers) - Growth, Future Prospects & Competitive Analysis, 2017 - 2025

Heart failure (HF) affects around 6 million Americans annually. Approximately 670,000 individuals have diagnosed with heart failure annually. It is the leading cause of death in comparison with cancer and other prolonged diseases. A mechanical circulatory support device enables the heart to work when it isn’t working at its best.

Nations with high-incomes are seeing an expanded occurrence of congestive heart failure issues because of the elevated adoption of the sedentary lifestyles leading to increased deaths due to heart failure. Other heart-related conditions, such as hypertension, coronary heart disease are also increasing globally. The high prevalence of congestive heart failure will boost the global circulatory support devices market in future. The surging number of patients experiencing congestive heart failure is driving the hospitalization rate across the globe.

In the American Heart Association/American College of Cardiology guidelines, heart failure is defined as “an intricate clinical syndrome that can outcome from any functional or structural cardiac disorder that damages the ability of the ventricle to fill or eject blood”. According to the Centers for Disease Control and Prevention (CDC), around 5.7 Mn individuals in the United States suffer from heart failure. Heart failure costs the nation an estimated 30.7 Bn each year, nearly half of the individuals who develop heart failure die within 5 years of diagnosis, hence it is expected that there is a rise in the demand of circulatory support devices in the future, which will further enhance the global market of circulatory support devices.

The tenacity of this study titled ‘Circulatory Support Devices Market - Future Prospects, Growth, and Competitive Analysis, 2017 – 2025’ is to offer investors, producers, business authorities and industry patrons with itemized investigation to permit them to take premeditated initiatives and resolutions related to the expectations in the global circulatory support devices market. This report offers and assesses the major circumstances prominent in the overall circulatory support devices market along with market size and forecast.

This report classifies the worldwide circulatory support devices market with respect to the usage areas, products, and geographical distribution. Depending on products types, the global circulatory support devices market is categorized into the total artificial heart (TAH), ventricular assist device (VAD), and extracorporeal membrane oxygenation (ECMO). The usage areas considered with the end goal of this study are hospitals and ambulatory surgical centers. Market size and prediction for every segment from 2015 to 2025 period is offered in the report with respective CAGRs for the forecast period 2017-2025.  

This report includes divisions accompanied by principal nations, which are familiarized as follows:

  • Europe
    • Germany
    • United Kingdom
    • Rest of Europe
  • North America
    • Canada       
    • United States
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

This detailed study offers the analysis of each segment for the term of 2015-2025 alongside the specific market assessment for the particular nations in their area-wise segments.

An inclusive study of market situations has been reported in the study to catch suitable understanding of the market and their trends. Several methods are used in the report to determine the rivalry among main market players. The research study also consists of company profiling of the different companies which have a hold in the global market for circulatory support devices market. Some of the key players in the global circulatory support devices market include St. Jude Medical, Inc., ReliantHeart Inc., Medtronic plc., Leviticus Cardio Ltd, Jarvik Heart Inc., Evaheart, Inc., CorWave, CHF Solutions, CardiacAssist, Inc., Berlin Heart GmbH, ABIOMED, Inc. and more.

Geographically, the global circulatory support devices market is composed of Latin America, Middle East & Africa, Europe, Asia Pacific, and North America.

Circulatory Support Devices Market

North America held the prime share in global circulatory support devices market attributing to major reasons such as high incidence of congestive heart failure, pulmonary related disease, and growing population augmenting the growth of circulatory support devices market. The need of circulatory support devices due to the rise in the number of heart patients will drive the global circulatory support devices market. During the course of forecast duration 2017 – 2025, Asia Pacific is observed as the fastest growing region due to key driving factors such as rising incidence of heart failure in developing countries, evolving healthcare expenditure, and growing awareness related with early treatment, and escalating demand for the advanced system.

The geographical classification of the global circulatory support devices market is as follows:

  • Asia Pacific (Japan, China, and Rest of Asia Pacific)
  • North America (Canada & United States)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
  • Europe (Germany, U.K., and Rest of Europe)
  • Latin America (Mexico, Brazil, and Rest of Latin America)
Choose License Type
Trusted By
Related Report

Published Date:  Apr 2018
Category:  Medical Devices
Report ID:   59102
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support